May 3, 2022 at 4:30 PM EDT
Keyword Search
- Summary ToggleInfinity Pharmaceuticals to Participate in Upcoming H.C. Wainwright Global Investment ConferenceMay 17, 2022 at 8:35 AM EDT
- Summary ToggleInfinity Pharmaceuticals Reports First Quarter 2022 Financial ResultsMay 3, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 8, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Company HighlightsMarch 29, 2022 at 4:05 PM EDT
- Summary ToggleInfinity Pharmaceuticals to Present at the 32nd Annual Oppenheimer Healthcare ConferenceMarch 9, 2022 at 8:35 AM EST
- Summary ToggleInfinity Pharmaceuticals to Be Featured in a Fireside Chat as Part of B. Riley’s 2022 Virtual Oncology ConferenceJanuary 20, 2022 at 8:35 AM EST
- Summary ToggleInfinity to Present at 40th Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2022 at 8:35 AM EST
- Summary ToggleInfinity Pharmaceuticals Outlines Eganelisib Clinical Development Strategy and Provides 2022 GuidanceJanuary 5, 2022 at 7:05 AM EST